Pre-pregnancy counseling for women with chronic kidney disease

Journal of Nephrology

Volumn 25, Issue 4, 2012, Pages 450-459

  Bramham, Kate ^a   Lightstone, Liz ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

CKD; Lupus nephritis; Pre pregnancy counseling; Transplant

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ADRENAL INSUFFICIENCY; ADULT POLYCYSTIC KIDNEY DISEASE; ANURIA; ARTICLE; CARDIOVASCULAR MALFORMATION; CATARACT; CENTRAL NERVOUS SYSTEM MALFORMATION; CHROMOSOME ABERRATION; CHRONIC KIDNEY DISEASE; CONCEPTION; CONGENITAL DISORDER; CONGENITAL MALFORMATION; CYTOPENIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; FETUS DEATH; GLOMERULUS FILTRATION RATE; GROWTH RETARDATION; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERKALEMIA; HYPERTENSION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DYSFUNCTION; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOTHER FETUS RELATIONSHIP; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PREPREGNANCY CARE; PROTEINURIA; REFLUX NEPHROPATHY; SIDE EFFECT; SKULL DISEASE; TREATMENT DURATION; TREATMENT PLANNING;

CHRONIC DISEASE; COUNSELING; FEMALE; HUMANS; KIDNEY DISEASES; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84863914283     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000130     Document Type: Article

References (86)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298 (17):2038-2047.
2. Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211-215.
3. Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14(2): 132-145.
4. Lightstone L. Preconception counselling and risk assessment: general overview. In: Davison JM, Nelson-Piercy C, Kehoe S, Baker P, eds. Renal disease in pregnancy. London: RCOG Press; 2008:21-30.
5. Fink JC, Schwartz SM, Benedetti TJ, Stehman-Breen CO. Increased risk of adverse maternal and infant outcomes among women with renal disease. Paediatr Perinat Epidemiol. 1998;12(3):277-287.
6. Nevis I F, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol. 2011;6(11):2587-2598.
7. Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG. 2008;115(1):109-112.
8. Alper AB, Yi Y, Rahman M, et al. Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. Am J Perinatol. 2011;28(6):425-430.
9. Abe S. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy. Clin Nephrol. 1994;41(2):61-64.
10. Bar J, Ben-Rafael Z, Padoa A, Orvieto R, Boner G, Hod M. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Nephrol. 2000;53(6):437-444.
11. Chapman AB, Johnson AM, Gabow PA. Pregnancy outcome and its relationship to progression of renal failure in autoso-mal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;5(5):1178-1185.
12. Jungers P, Houillier P, Chauveau D, et al. Pregnancy in women with reflux nephropathy. Kidney Int. 1996;50(2):593-599.
13. Limardo M, Imbasciati E, Ravani P, et al; Rene e Gravidanza Collaborative Group of the Italian Society of Nephrology. Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study. Am J Kidney Dis. 2010;56(3): 506-512.
14. Lightstone L. Post partum follow up of antenatally identified problems. In: Davison JM, Nelson-Piercy C, Kehoe S, Baker P, eds. Renal disease in pregnancy. London: RCOG Press; 2008:53-60.
15. Bar J, Chen R, Schoenfeld A, et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab. 1999;12(5):659-665.
16. Abe S. An overview of pregnancy in women with underlying renal disease. Am J Kidney Dis. 1991;17(2):112-115.
17. Barceló P, López-Lillo J, Cabero L, Del Río G. Successful pregnancy in primary glomerular disease. Kidney Int. 1986; 30(6):914-919.
18. Katz AI, Davison JM, Hayslett J P, Singson E, Lindheimer MD. Pregnancy in women with kidney disease. Kidney Int. 1980;18(2):192-206.
19. Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844-855.
20. Piccoli GB, Conijn A, Attini R, et al. Pregnancy in chronic kidney disease: need for a common language. J Nephrol. 2011; 24(3):282-299.
21. Imbasciati E, Ponticelli C. Pregnancy and renal disease: predictors for fetal and maternal outcome. Am J Nephrol. 1991;11(5):353-362.
22. Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2): 519-525.
23. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005;14(1):89-94.
24. Kuo VS, Koumantakis G, Gallery ED. Proteinuria and its assessment in normal and hypertensive pregnancy. Am J Ob-stet Gynecol. 1992;167(3):723-728.
25. Stratta P, Canavese C, Quaglia M. Pregnancy in patients with kidney disease. J Nephrol. 2006;19(2):135-143.
26. Galdo T, González F, Espinoza M, et al. Impact of pregnancy on the function of transplanted kidneys. Transplant Proc. 2005;37(3):1577-1579.
27. Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophospha-mide-induced ovarian failure. N Engl J Med. 1973;289(22): 1159-1162.
28. Ioannidis J P, Katsifis GE, Tzioufas AG, Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2002;29(10):2129-2135.
29. Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus. 2004;13(8):569-574.
30. Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009;18(3):311-319.
31. Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38(9):1906-1913.
32. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythemato-sus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11): 2060-2068.
33. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514-521.
34. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefe-bvre G, Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis. 2001;60(6):599-604.
35. Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18(4):342-347.
36. Tandon A, Ibañez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis Rheum. 2004; 50(12):3941-3946.
37. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am. 1997;23(1):1-13.
38. Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35(2): 133-138.
39. Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis. 2007;49(6):753-762.
40. McGrory CH, McCloskey LJ, DeHoratius RJ, Dunn SR, Moritz MJ, Armenti VT. Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant. 2003;3(1):35-42.
41. Lane CR, Trow TK. Pregnancy and pulmonary hypertension. Clin Chest Med. 2011;32(1):165-174, x.
42. Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis. 2002;40(4):713-720.
43. Nelson-Piercy C, Rosene-Montella K. Systemic lupus erythematosus In: Rosene-Montella K, ed. Medical care of the pregnant patient. 2nd ed. Philadelphia, PA: American College of Physicians; 2008:784.
44. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis. 1999;33(2):235-252.
45. Abe S, Amagasaki Y, Konishi K, Kato E, Sakaguchi H, Iyori S. The influence of antecedent renal disease on pregnancy. Am J Obstet Gynecol. 1985;153(5):508-514.
46. Hou S. Pregnancy in women with chronic renal disease. N Engl J Med. 1985;312(13):836-839.
47. Jones DC, Hayslett J P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4):226-232.
48. Jungers P, Chauveau D, Choukroun G, et al. Pregnancy in women with impaired renal function. Clin Nephrol. 1997; 47(5):281-288.
49. Packham DK, North RA, Fairley KF, Kloss M, Whitworth JA, Kincaid-Smith P. Primary glomerulonephritis and pregnancy. Q J Med. 1989;71(266):537-553.
50. Davison JM, Noble MC. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol. 1981;88(1):10-17.
51. Bramham K, Briley AL, Seed PT, Poston L, Shennan AH, Chappell LC. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci. 2011; 18(7):623-630.
52. Plant L. Pregnancy and dialysis. In: Davison JM, Nelson-Piercy C, Kehoe S, Baker P, eds. Renal disease in pregnancy. London: RCOG Press; 2008:272.
53. Hou SH, Grossman SD, Madias NE. Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med. 1985;78(2):185-194.
54. Imbasciati E, Pardi G, Capetta P, et al. Pregnancy in women with chronic renal failure. Am J Nephrol. 1986;6(3):193-198.
55. Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3(2):392-396.
56. Chao AS, Huang JY, Lien R, Kung FT, Chen PJ, Hsieh PC. Pregnancy in women who undergo long-term hemodialysis. Am J Obstet Gynecol. 2002;187(1):152-156.
57. Haase M, Morgera S, Bamberg C, et al. A systematic approach to managing pregnant dialysis patients: the importance of an intensified haemodiafiltration protocol. Nephrol Dial Transplant. 2005;20(11):2537-2542.
58. Luders C, Castro MC, Titan SM, et al. Obstetric outcome in pregnant women on long-term dialysis: a case series. Am J Kidney Dis. 2010;56(1):77-85.
59. Chan WS, Okun N, Kjellstrand CM. Pregnancy in chronic dialysis: a review and analysis of the literature. Int J Artif Organs. 1998;21(5):259-268.
60. Giatras I, Levy D P, Malone FD, Carlson JA, Jungers P. Pregnancy during dialysis: case report and management guidelines. Nephrol Dial Transplant. 1998;13(12):3266-3272.
61. Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis. 1998;31(5):766-773.
62. Asamiya Y, Otsubo S, Matsuda Y, et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int. 2009;75(11):1217-1222.
63. Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and dialysis. Am J Kidney Dis. 1998;31(5):756-765.
64. Holley JL, Reddy SS. Pregnancy in dialysis patients: a review of outcomes, complications, and management. Semin Dial. 2003;16(5):384-388.
65. Hou S. Peritoneal dialysis and haemodialysis in pregnancy. Baillieres Clin Obstet Gynaecol. 1987;1(4):1009-1025.
66. Chang H, Miller MA, Bruns FJ. Tidal peritoneal dialysis during pregnancy improves clearance and abdominal symptoms. Perit Dial Int. 2002;22(2):272-274.
67. Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res. 2003;29(4):227-233.
68. Crowe AV, Rustom R, Gradden C, et al. Pregnancy does not adversely affect renal transplant function. QJM. 1999;92 (11):631-635.
69. Fischer T, Neumayer HH, Fischer R, et al. Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine. Am J Transplant. 2005;5(11):2732-2739.
70. Gutiérrez MJ, Acebedo-Ribó M, García-Donaire JA, et al. Pregnancy in renal transplant recipients. Transplant Proc. 2005;37(9):3721-3722.
71. Keitel E, Bruno RM, Duarte M, et al. Pregnancy outcome after renal transplantation. Transplant Proc. 2004;36(4):870-871.
72. Stratta P, Canavese C, Giacchino F, Mesiano P, Quaglia M, Rossetti M. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol. 2003;16(6):792-806.
73. Armenti VT, Moritz MJ, Davison JM. Medical management of the pregnant transplant recipient. Adv Ren Replace Ther. 1998;5(1):14-23.
74. Deshpande NA, James NT, Kucirka LM, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11(11):2388-2404.
75. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation: Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002;17(Suppl 4):50-55.
76. Gargollo PC, Diamond DA. Therapy insight: what nephrologists need to know about primary vesicoureteral reflux. Nat Clin Pract Nephrol. 2007;3(10):551-563.
77. Hayslett J P. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol. 1992;28(3-4):199-204.
78. Hadden D, Traub A, Lowy C, et al. Outcome of pregnancy in women with insulin dependent diabetes: centralisation of care leads to better outcome. BMJ. 1998;316(7130):550 [author reply: 551-552].
79. CEMACH. Confidential enquiry into maternal and child health: pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH; 2005.
80. Østensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.
81. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet A F, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82(12):1698-1702.
82. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004:103-114.
83. Chusney GD, Bramham K, Nelson-Piercy C, et al. Tacrolimus monitoring during breastfeeding in neonates of transplant recipients. Ther Drug Monit. 2011;33:476.
84. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-2451.
85. Kyle PM. Drugs and the fetus. Curr Opin Obstet Gynecol. 2006;18(2):93-99.
86. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659.